What is the best prediction molecular panel for UC? <i>ATM</i> mutation is associated with shorter overall survival in relapsed/advanced urothelial cancer. ascopubs.org/doi/abs/10.120…

There are now roughly 10 administrators for every doctor. If we converted even half of those salary lines to additional nurses and doctors, we might have enough clinical staff members to handle the work.

Thanks to Mutahar Ahmed and Intuitive for having me watch how an efficient SP robotics OR can be run. One day 7 cases (SP SPAM partial, SP RPLND, SP EP RARPx2, XI RARP x3)

What an incredible experience in San Francisco at ASCO-GU 2024! Our WUTSUP-02 trial was chosen for the poster session. The ADC can benefit platinum-ineligible patients, potentially transforming UTUC neoadjuvant treatment. #ASCOGU2024 #WUTSUP02 #UTUC #NeoadjuvantTreatment

Exciting news! Our data from the high-risk UTUC nephron-sparing trial has been accepted at ESMO 2024! Demonstrating the potential to preserve kidneys in carefully selected high-risk UTUC patients. #ESMO2024 #UTUC #NephronSparing